JAMA Surg:癌症患者大型外科手术后静脉栓塞的发生率增高而死亡率下降

2013-11-20 MedSci MedSci原创

Montreal Health Centre大学的Vincent Q. Trinh等的研究发表在JAMA Surgery,文章评估了1999年至2009年间美国癌症患者进行大型外科手术后静脉血栓栓塞(VTE)的发生率和死亡率,他们发现这11年间静脉血栓栓塞的发生率增加,死亡率则明显降低。研究中,从1999年1月至2009年12月全国住院患者中,回顾性筛选出因癌症而行结肠切除术、胆囊切除术、食管切除

Montreal Health Centre大学的Vincent Q. Trinh等的研究发表在JAMA Surgery,文章评估了1999年至2009年间美国癌症患者进行大型外科手术后静脉血栓栓塞(VTE)的发生率和死亡率,他们发现这11年间静脉血栓栓塞的发生率增加,死亡率则明显降低。研究中,从1999年1月至2009年12月全国住院患者中,回顾性筛选出因癌症而行结肠切除术、胆囊切除术、食管切除术、胃切除术、子宫切除术、肺切除术、胰腺切除术或前列腺切除术的患者。外科手术后静脉血栓栓塞的评估根据日期、病人和住院特征等评估,住院静脉血栓栓塞的决定因素通过logistic回归分析。

静脉血栓栓塞和死亡率

对2,508,916例癌症大手术后的患者进行统计分析,有33,409例患者发生外科术后住院血栓栓塞(1.3%)。估测静脉血栓栓塞年发生率增加4.0% (P < .001),而静脉血栓栓塞死亡率呈下降趋势,年估测发生率为2.4%(P = .03)。同一时期大型手术后年死亡率下降2.4%(P < .001)。

静脉血栓栓塞的风险因素

logistic 回归分析中校正了手术年份、年龄、基线Charlson共患病指数、家庭收入(中位数)、医院位置、手术医院(教学医院)等指标发现,高龄(odds ratio [OR] = 1.03, P <0 .001)、女性(OR = 1.25, P <0 .001)、黑人(OR = 1.56, P< .001, vs white)、Charlson共患病指数积分≥3(OR = 1.85, P < .001)、医疗补助保险(OR = 2.04,P < 0.001)、医疗保险(OR = 1.39, P <0 .001)和无保险(OR = 1.49, P <0 .001; 与私人保险对比)。非白种人和非黑种人的静脉血栓栓塞危险降低(OR = 0.75, P < 0.001)等因素显著增加静脉血栓栓塞危险。 

在城市医院(OR = 1.32, P < 0.001)和教学医院(OR = 1.08, P = 0.01)接受治疗与静脉血栓栓塞危险显著增加有关。与北部相比,在中部(OR = 0.90, P =0 .01)、南部(OR = 0.89, P = 0.001)和西部(OR = 0.88, P = .001)医院接受治疗显著降低静脉血栓栓塞危险。

死亡率

总体上,肿瘤患者大手术后死亡率为2.0%,食管切除术后死亡率为7.2%,胃切除术后为5.7%,胰腺切除术后为4.9%,结肠切除术后为3.1%,肺切除术后为2.9%, 胆囊切除术后为2.5%,子宫切除术后为0.4%,前列腺切除术后为0.1%。

多变量回归分析中,有VTE者死亡风险是无VTE者的5.3倍(12.0% vs 1.9%, OR = 5.30, P < 0.001),评估单个手术后VTE的死亡风险后,结肠切除术VTE死亡风险增加的OR值为3.74(11.3% vs 2.9%, P < 0.001),胆囊切除术为4.58(9.6% vs 2.3%, P <0.001),食管切除术为2.01(13.6% vs 6.9%, P = 0.02),胃切除术为2.81(14.7% vs 5.5%, P <0 .001),子宫切除术为10.93(5.2%vs 0.3%, P < 0.001),肺切除术为8.73(19.8% vs 2.6%, P <.001),胰腺切除术为3.08(13.2% vs 4.7%, P <0 .001),前列腺切除为56.42(3.9% vs 0.1%, P < 0.001)。 

因此,本研究表明,肿瘤患者大手术后VTE事件发生率增加,但是,与VTE相关的死亡降低。另外,ASCO今年也更新癌症患者静脉血栓栓塞防治威廉亚洲博彩公司 (见:JCO:ASCO更新癌症患者静脉血栓栓塞防治威廉亚洲博彩公司


原始出处:
Trinh VQ, Karakiewicz PI, Sammon J, Sun M, Sukumar S, Gervais MK, Shariat SF, Tian Z, Kim SP, Kowalczyk KJ, Hu JC, Menon M, Trinh QD. Venous Thromboembolism After Major Cancer Surgery: Temporal Trends and Patterns of Care. JAMA Surg. 2013 Nov 6. doi: 10.1001/jamasurg.2013.3172.

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1697187, encodeId=6122169e18761, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jan 29 06:33:00 CST 2014, time=2014-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826240, encodeId=c46f18262407c, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Mar 13 18:33:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289428, encodeId=a7d91289428d7, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343267, encodeId=9f4f134326e63, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561555, encodeId=e56c156155562, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567564, encodeId=c78c156e56492, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=)]
    2014-01-29 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1697187, encodeId=6122169e18761, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jan 29 06:33:00 CST 2014, time=2014-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826240, encodeId=c46f18262407c, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Mar 13 18:33:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289428, encodeId=a7d91289428d7, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343267, encodeId=9f4f134326e63, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561555, encodeId=e56c156155562, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567564, encodeId=c78c156e56492, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1697187, encodeId=6122169e18761, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jan 29 06:33:00 CST 2014, time=2014-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826240, encodeId=c46f18262407c, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Mar 13 18:33:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289428, encodeId=a7d91289428d7, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343267, encodeId=9f4f134326e63, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561555, encodeId=e56c156155562, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567564, encodeId=c78c156e56492, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1697187, encodeId=6122169e18761, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jan 29 06:33:00 CST 2014, time=2014-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826240, encodeId=c46f18262407c, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Mar 13 18:33:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289428, encodeId=a7d91289428d7, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343267, encodeId=9f4f134326e63, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561555, encodeId=e56c156155562, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567564, encodeId=c78c156e56492, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1697187, encodeId=6122169e18761, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jan 29 06:33:00 CST 2014, time=2014-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826240, encodeId=c46f18262407c, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Mar 13 18:33:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289428, encodeId=a7d91289428d7, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343267, encodeId=9f4f134326e63, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561555, encodeId=e56c156155562, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567564, encodeId=c78c156e56492, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=)]
    2013-11-22 liuxiaona
  6. [GetPortalCommentsPageByObjectIdResponse(id=1697187, encodeId=6122169e18761, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Jan 29 06:33:00 CST 2014, time=2014-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826240, encodeId=c46f18262407c, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Thu Mar 13 18:33:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1289428, encodeId=a7d91289428d7, content=<a href='/topic/show?id=cbb8e1356f7' target=_blank style='color:#2F92EE;'>#癌症患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71356, encryptionId=cbb8e1356f7, topicName=癌症患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343267, encodeId=9f4f134326e63, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561555, encodeId=e56c156155562, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567564, encodeId=c78c156e56492, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Fri Nov 22 01:33:00 CST 2013, time=2013-11-22, status=1, ipAttribution=)]
    2013-11-22 liuxiaona